Skip to main content

Biocon Biologics refinances 1.1 billion debt through US dollar bonds and new syndicated facility

03 تشرين الأول 2024
The bonds will be issued by Biocon Biologics Global plc which is a wholly owned subsidiary of BBL and will be backed by a strong security package, the company said.

For more details: Click here